DK160686D0 - Tri- og tetracycliske forbindelser - Google Patents
Tri- og tetracycliske forbindelserInfo
- Publication number
- DK160686D0 DK160686D0 DK160686A DK160686A DK160686D0 DK 160686 D0 DK160686 D0 DK 160686D0 DK 160686 A DK160686 A DK 160686A DK 160686 A DK160686 A DK 160686A DK 160686 D0 DK160686 D0 DK 160686D0
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- image
- phenyl
- compounds
- naphthyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- -1 phenylalkenyl Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 230000002213 calciumantagonistic effect Effects 0.000 abstract 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/12—[b,e]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16853284 | 1984-08-10 | ||
| JP59168532A JPS6147466A (ja) | 1984-08-10 | 1984-08-10 | アミン誘導体 |
| PCT/JP1985/000445 WO1986001203A1 (en) | 1984-08-10 | 1985-08-09 | Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them |
| JP8500445 | 1985-08-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK160686D0 true DK160686D0 (da) | 1986-04-09 |
| DK160686A DK160686A (da) | 1986-04-09 |
| DK168918B1 DK168918B1 (da) | 1994-07-11 |
Family
ID=15869764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK160686A DK168918B1 (da) | 1984-08-10 | 1986-04-09 | Tri- og tetracycliske forbindelser med en omega-(4-substitueret-1-(homo)piperazinyl)alkanoylaminogruppe, fremgangsmåde til fremstilling af forbindelserne samt præparat indeholdende forbindelserne som aktiv bestanddel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4749703A (da) |
| EP (1) | EP0191867B1 (da) |
| JP (1) | JPS6147466A (da) |
| KR (1) | KR920003198B1 (da) |
| AT (1) | ATE68484T1 (da) |
| AU (1) | AU572690B2 (da) |
| CA (1) | CA1265788A (da) |
| DE (1) | DE3584442D1 (da) |
| DK (1) | DK168918B1 (da) |
| MX (1) | MX9202782A (da) |
| WO (1) | WO1986001203A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8500273D0 (sv) * | 1985-01-22 | 1985-01-22 | Leo Ab | Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder |
| NZ223875A (en) * | 1987-03-17 | 1991-01-29 | Hoechst Roussel Pharma | 9-aminotetrahydroacridines and related homologues and pharmaceutical compositions |
| US4882351A (en) * | 1987-10-14 | 1989-11-21 | Roussel Uclaf | Tricyclic compounds |
| AU612437B2 (en) * | 1987-12-14 | 1991-07-11 | Kyowa Hakko Kogyo Co. Ltd. | Tricyclic compounds |
| US4999363A (en) * | 1988-06-09 | 1991-03-12 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds |
| US5242931A (en) * | 1988-06-09 | 1993-09-07 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds as TXA2 antagonists |
| CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
| WO1993005778A1 (en) * | 1991-09-24 | 1993-04-01 | Dainippon Pharmaceutical Co., Ltd. | Blood lipid metabolism ameliorant |
| US5643909A (en) * | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
| KR100502229B1 (ko) * | 1995-02-28 | 2005-11-08 | 다이이찌 산토리 파마 가부시키가이샤 | 아릴피페리딘및아릴피페라진유도체,및이를함유하는약제 |
| TWI267511B (en) * | 1999-06-03 | 2006-12-01 | Lilly Co Eli | Process for preparing 10,11-methanobenzosuberane derivatives |
| JP2005531571A (ja) * | 2002-05-23 | 2005-10-20 | アボット・ラボラトリーズ | 性機能不全の治療に有用なアセトアミド類およびベンズアミド類 |
| EP1611116A2 (en) * | 2003-04-08 | 2006-01-04 | Neuromed Technologies, Inc. | Calcium channel inhibitors comprising benzhydril spaced from piperazine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB210533A (en) * | 1922-11-02 | 1924-02-04 | Reginald Charles Reid | Improvements in or relating to apparatus for grinding and polishing lenses and the like |
| US3954777A (en) * | 1970-03-03 | 1976-05-04 | Zambon S.P.A. | Aminopropionyl derivatives of 2,3-diphenyl cyclopropylamine |
| GB1347935A (en) * | 1971-04-10 | 1974-02-27 | Yoshitomi Pharmaceutical | Piperazine derivatives methods for their production and phar maceutical compositions containing them |
| JPS553353B1 (da) * | 1971-04-10 | 1980-01-24 | ||
| IT1054961B (it) * | 1976-01-23 | 1981-11-30 | Corvi Camillo Spa | Derivati della piperazina adatti come agenti anti ulcera |
| JPS6059177B2 (ja) * | 1978-06-24 | 1985-12-24 | 日本電信電話株式会社 | 無水石英ガラスの製造方法 |
| CS210369B1 (cs) * | 1980-10-01 | 1982-01-29 | Miroslav Rajsner | Nové deriváty 6,11-dihydrodibenzo(b,e)thiepin-5,5-dioxidu, jejich soli a způsob jejich přípravy |
| ZA825719B (en) * | 1981-09-03 | 1983-06-29 | Recordati Chem Pharm | Alkanoylanilides |
| JPS5896075A (ja) * | 1981-12-03 | 1983-06-07 | Hokuriku Seiyaku Co Ltd | １−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体 |
| US4457931A (en) * | 1982-09-27 | 1984-07-03 | Selvi & C. S.P.A. | Piperazine derivatives with anticholinergic and/or antihistaminic activity |
-
1984
- 1984-08-10 JP JP59168532A patent/JPS6147466A/ja active Granted
-
1985
- 1985-08-09 WO PCT/JP1985/000445 patent/WO1986001203A1/ja active IP Right Grant
- 1985-08-09 AT AT85904018T patent/ATE68484T1/de not_active IP Right Cessation
- 1985-08-09 US US06/855,849 patent/US4749703A/en not_active Expired - Fee Related
- 1985-08-09 KR KR1019860700202A patent/KR920003198B1/ko not_active Expired
- 1985-08-09 EP EP85904018A patent/EP0191867B1/en not_active Expired - Lifetime
- 1985-08-09 AU AU47219/85A patent/AU572690B2/en not_active Ceased
- 1985-08-09 DE DE8585904018T patent/DE3584442D1/de not_active Expired - Lifetime
-
1986
- 1986-01-31 CA CA000500867A patent/CA1265788A/en not_active Expired - Lifetime
- 1986-04-09 DK DK160686A patent/DK168918B1/da not_active IP Right Cessation
-
1992
- 1992-06-10 MX MX9202782A patent/MX9202782A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986001203A1 (en) | 1986-02-27 |
| CA1265788A (en) | 1990-02-13 |
| MX9202782A (es) | 1992-06-30 |
| DK168918B1 (da) | 1994-07-11 |
| KR860700251A (ko) | 1986-08-01 |
| JPH0358341B2 (da) | 1991-09-05 |
| EP0191867B1 (en) | 1991-10-16 |
| DE3584442D1 (de) | 1991-11-21 |
| AU572690B2 (en) | 1988-05-12 |
| EP0191867A4 (en) | 1987-09-02 |
| ATE68484T1 (de) | 1991-11-15 |
| KR920003198B1 (ko) | 1992-04-24 |
| EP0191867A1 (en) | 1986-08-27 |
| US4749703A (en) | 1988-06-07 |
| DK160686A (da) | 1986-04-09 |
| AU4721985A (en) | 1986-03-07 |
| JPS6147466A (ja) | 1986-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3271269D1 (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| GR3005315T3 (da) | ||
| DK160686D0 (da) | Tri- og tetracycliske forbindelser | |
| DE3781080D1 (de) | 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung. | |
| DE2960820D1 (en) | Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| MA23639A1 (fr) | Derives pyrrocarbazole, leur preparation, les compositions pharmaceutiques les contenant, leur utilisation dans le traitement des tumeurs malignes. | |
| ES8506629A1 (es) | Un procedimiento para preparar derivados de piridina | |
| DE68917357D1 (de) | Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten. | |
| HU900141D0 (en) | Process for preparation of new 1,8 benzonapthridine-derivatives and for manufacturing of the pharmaceutical composition containing these compounds | |
| ES2012507A6 (es) | Un procedimiento para la preparacion de derivados de b-lactama. | |
| ES2046641T3 (es) | Composicion antitumoral. | |
| ES482285A1 (es) | Procedimiento de preparacion de compuestos de benzofurano. | |
| HUT50337A (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds | |
| FR2618436B1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| DE69110217D1 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| NO166321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser. | |
| SE8801945D0 (sv) | New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes | |
| SE8903312D0 (sv) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them | |
| ES8205804A1 (es) | Un procedimiento para la preparacio,n de nuevos derivados de denzopirano 2,3-d-v-triazol. | |
| IL95377A0 (en) | Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type | |
| HUT58070A (en) | Process for producing brackets open (1-arylpyrrolidin-2-yl)-methyl brackets closed-piperazine derivatives and pharmaceutical compositions comprising these derivatives as active ingredient | |
| PH23966A (en) | Imidazoquinozoline compounds as agent for treatment of nephritis | |
| FR2655042B1 (fr) | Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| SE8701524L (sv) | Nya sulfonamider och deras framstaellningsfoerfarande |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |